Tesamorelin vs Sermorelin

Tesamorelin wins for: rapid, clinically-proven visceral and hepatic fat loss; maximal effect size on VAT; utility in reversing AAS/HGH-induced abdominal distension; data-backed reduction in NAFLD markers.

Sermorelin wins for: overall safety, low side effect load, flexible use as a wellness, recovery, or longevity peptide; minimal impact on glucose and insulin resistance; widest use-case compatibility for people seeking gentle GH-axis support without aggressive intervention.

Pick Tesamorelin if:

• Your primary goal is aggressive visceral fat (VAT) and liver fat reduction proven in human trials
• You need to shrink HGH/AAS-induced "GH gut" or have high NAFLD risk markers
• You want quantifiable metabolic improvements in 12-24 weeks
• You're fine with daily sub-cu dosing and monitoring glucose/IGF-1 more closely
• You want something with hard clinical endpoints, not just anecdotal wellness

Pick Sermorelin if:

• You're looking for a safe, long-term GH-axis peptide for sleep, recovery, and subtle recomp
• You prefer minimal impact on carb sensitivity and are insulin-resistant or prediabetic
• You want a feedback-regulated, natural feeling rather than aggressive pharmacology
• You're stacking with ipamorelin or other GHRPs for broader recovery and slow-burn physique change
• You care more about overall wellness, joint support, or anti-aging than rapid fat loss